info icon

This is a non-core endpoint: only basic statistics are computed.

Injection of e.g. viscoelastic gel into the vitreous cavity

DM_EYE_OPER_INJECT_GEL_VITR

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector
diagram bullet

Check conditions

DIABETES_FG

71098

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Operations: NOMESCO codes ^CKD15

1 out of 7 registries used, show all original rules.

216

diagram downward connector

Check minimum number of events None

216

diagram downward connector

Include endpoints None

216

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

213

diagram downward connector
DM_EYE_OPER_INJECT_GEL_VITR

Control definitions

Control exclude DM_EYE_OPER
Control conditions not DIABETES_FG

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 213 84 129
Unadjusted prevalence (%) 0.06 0.04 0.08
Mean age at first event (years) 52.30 48.50 54.78

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: DM_EYE_OPER_INJECT_GEL_VITR – Injection of e.g. viscoelastic gel into the vitreous cavity
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Injection of e.g. viscoelastic gel into the vitreous cavity

Endpoint not on priority list, no data to show.